The Japanese Society For Replacement Arthroplasty The Japan Arthroplasty Register 2017/3/31
90000 Total:88038 cases 80000 70000 60000 50000 40000 30000 20000 10000 0 2006 2007 20082009 20102011 2012 20132014 2015 20162017
unknow n 0.10% unknow n 0.15% male 18.64% male 21.08% female 81.26% female 78.77%
cases cases 45000 42,134 1200 1152 40000 35000 30000 1000 800 805 25000 20000 15000 16,284 22,593 600 400 512 10000 5000 0 3,170 10 16 119 481 483 2 52 10 20 30 40 50 60 70 80 90 100 200 0 138 0 4 6 30 44 3 10 20 30 40 50 60 70 80 90 age age
Trauma 0.34% ION 3.26% RA 7.24% Charcot's joint 0.12% The others 0.68% 0.28% joint Trauma0.22% 0.89% ION 2.74% Charcot's The others 2.03% 5.25% OA 88.09% RA 16.75% OA 72.13%
cases 30000 25000 20000 15000 10000 5000 0 98 9890 27686 26708 13892 4870 1372 397 150 44 19 10 2 7 10 min cases 600 500 400 300 200 100 0 19 177 345 480 547 403 302 179 110 49 35 13 6 8 2 min
lateralthe others 0.89% 2.60% QS 2.35% sub-vastus 4.45% 0.22% sub-vastus 0.78% lateral 1.11% QS 1.67% mid-vastus 9.43% The others 2.26% blank 0.56% mid-vastus 28.35% parapatella 61.14% parapatella 84.19%
Hybrid 0.24% 5.20% cementless 11.11% cement 83.45% unknow n 0.15% cement 26.01% cementl ess 73.84% ALAC 0.88% Hybrid 2.43% cementless 14.68% unknow n 0.09% cementl ess 41.00% cement 58.91% cement 82.02% ALAC
none 86.53% 80.21% chip, small autograft (femur) 6.07% 4.12% chip, small autograft (femur+tibia) 2.32% 2.76% chip, small autograft (femur+tibia+patella) 0.01% - chip, small autograft (femur+patella) 0.01% - chip, small autograft (tibia) 3.75% 3.93% chip, small autograft (tibia+patella) 0.005% 0.08% chip, small autograft (patella) 0.02% 0.12% chip, small allograft (femur) 0.05% 0.62% chip, small allograft (femur+tibia) 0.02% 0.74% chip, small allograft (femur+tibia+patella) - 0.04% chip, small allograft (tibia) 0.04% 0.74% chip, small allograft (patella) 0.001% - block, large autograft (femur) 0.20% 0.70% block, large autograft (femur+tibia) 0.12% 0.93% block, large autograft (femur+tibia+patella) 0.004% 0.04% block, large autograft (femur+patella) 0.001% - block, large autograft (tibia) 0.79% 0.97% block, large autograft (patella) 0.005% - block, large allograft (femur) 0.01% 0.97% block, large allograft (femur+tibia) 0.01% 1.48% block, large allograft (femur+tibia+patella) - 0.19% block, large allograft (femur+patella) - 0.04% block, large allograft (tibia) 0.02% 1.21% block, large allograft (tibia+patella) - 0.04% block, large allograft (patella) 0.001% 0.08%
0.43% Navi+ 9.09% 0.90% Navi+ 1.28% Navi- 90.48% Navi- 97.82%
unknow n 0.26% Non-MIS 71.64% MIS 28.10% Non- MIS 19.84% UKA MIS 79.96% unkno wn 0.19% unknow n 0.64% Non-MIS 90.07% MIS 9.29% UKA Non- MIS 55.56% MIS 44.44%
0.23% 1.05% No replace 47.50% replace 52.26% No replace 57.97% replace 40.98%
0.40% use 2.58% 0.54% Non-use 97.02% Non-use 50.60% use 48.86%
n=2694 multiple answers allowed Loosening (femur) 502 Loosening (patella) 43 Loosening (tibia) 668 Infection 884 Polyethylene wear (tibia) 362 Polyethylene wear (patella) 63 Implant breakage (femur) 20 Implant breakage (tibia) 78 Implant breakage (patella) 27 Trauma 56 Dislocation instability 319 Excursion restrictions 78 The others 377
cases 15000 10000 5000 para-patella mid-vastus sub-vastus lateral QS cases 500 0 30 31~60 61~90 91~120 121~150 151~180 181~210 211~240 241 min 400 300 200 100 para-patella mid-vastus sub-vastus lateral QS 0 30 31~60 61~90 91~120 121~150 151~180 181~210 211~240 241 min
para-patella mid-vastus sub-vastus lateral QS 6% 3% 14% 80% 14% 83% 7% 4% 89% 1% 16% 83% 2% 15% 83% 25% 5% 70% 5% 4% 91% 4% 8% 88% 1% 2% 97% 42% 58% 0%
cases 35000 30000 25000 20000 15000 10000 5000 0 cases 1000 800 600 400 200 10 20 30 40 50 60 70 80 90 100 age cement Hybrid cementless cement Hybrid cementless 0 20 30 40 50 60 70 80 90 age
Implant companies Target operation:85219 cases Maker s name Zimmer Biomet 46.64% Stryker 16.91% Depuy Synthes 13.73% Smith&Nephew 7.38% Kyocera Medical 5.63% Teijin Nakashima Medical 3.71% MicroPort Orthopedics 2.64% B.Braun Aesculap 0.95% Exactech 0.80% ORTHO DEVELOPMENT 0.75% Target operation: 1696 cases Maker s name Zimmer Biomet 56.43% Stryker 19.58% Depuy Synthes 8.49% Smith&Nephew 7.08% Kyocera Medical 3.54% Waldemar LINK 1.59% Teijin Nakashima Medical 1.12% MicroPort Orthopedics 0.88% ORTHO DEVELOPMENT 0.83% Exactech 0.29% Senko Medical Instrument Mfg(Mera) 0.39% Medacta 0.32%
Implant goods Target operation:85218 cases Target operation:1696 cases Maker s name Product name Maker s name Product name Zimmer Biomet NEXGEN 22.52% Zimmer Biomet VANGUARD 15.35% Stryker Scorpio 9.95% Depuy Synthes LCS 4.96% Stryker Triathlon 6.68% Smith&Nephew GENESIS 3.73% Zimmer Biomet UNICOMPARTMENTAL KNEE SYSTEM 4.13% Zimmer Biomet Oxford 3.50% Kyocera Medical Total knee prosthesis femur component GB03 KU4+ 1.35% Zimmer Biomet PERSONA 4.72% Depuy Synthes ATTUNE 3.40% Teijin Nakashima Medical FINE Total knee prosthesis 2.07% Smith&Nephew LEGION 2.17% Kyocera Medical Bi-Surface 2.67% MicroPort Orthopedics ADVANCE 1.29% Teijin Nakashima Medical FNK Total knee prosthesis 1.28% Zimmer Biomet NEXGEN 41.04% Stryker Scorpio 9.96% Zimmer Biomet VANGUARD 11.32% Stryker Triathlon 7.19% Smith&Nephew GENESIS 3.60% Depuy Synthes P.F.C. SIGMA 2.89% Depuy Synthes SIGMA 4.01% Waldemar LINK LINK Total knee prosthesis system 1.53% Depuy Synthes LCS 1.30% Zimmer Biomet OSS 1.53% Zimmer Biomet PERSONA 1.18% Teijin Nakashima Medical FNK Total knee prosthesis 1.00% Kyocera Medical Hinge type 1.12% Kyocera Medical PHYSIO-KNEE SYSTEM 1.12% MicroPort Orthopedics ADVANCE 0.83% The others 10.38% Depuy Synthes P.F.C. SIGMA 1.21% MicroPort Orthopedics EVOLUTION 1.34% The others 7.66%
Bioactive materials Target operation:2379 cases Product name Superpore 55.40% Artificial bone implant apaceram 19.36% Bone prosthetic material β bone 10.92% Boneceram-P 10.21% Neobone 2.90% Bone prosthetic material OSferion 0.46% Bone prosthetic material OSferion 60 0.34% The others 0.42% Target operation:117 cases Product name Boneceram-P 39.83% Artificial bone implant apaceram 11.86% Biopex(R) 11.02% Bone prosthetic material OSferion 8.47% Neobone 5.93% Bone prosthetic material OStinato 5.08% Superpore 5.08% The others 12.71%